Pharmaids Pharmaceuticals Limited (BOM:524572)

Market Cap	1.27B -45.7%
Revenue (ttm)	255.33M -14.2%
Net Income	-138.47M
EPS	-3.91
Shares Out	35.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,251
Average Volume	17,666
Open	39.30
Previous Close	34.86
Day's Range	34.00 - 39.30
52-Week Range	30.00 - 75.95
Beta	-0.10
RSI	45.86
Earnings Date	Feb 12, 2026

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-1...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 28
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524572

Financial Performance

In fiscal year 2025, Pharmaids Pharmaceuticals's revenue was 195.14 million, an increase of 27.54% compared to the previous year's 153.00 million. Losses were -107.77 million, 35.2% more than in 2024.